中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2013年
12期
1187-1189
,共3页
宫颈癌%诱导化疗%顺铂%紫杉醇
宮頸癌%誘導化療%順鉑%紫杉醇
궁경암%유도화료%순박%자삼순
Cervical cancer%Induction chemotherapy%Cisplatin%Paclitaxel
目的:评价紫杉醇脂质体联合顺铂方案作为诱导化疗在宫颈癌治疗中的抗肿瘤作用及毒性。方法选择晚期宫颈癌患者73例,按照住院单、双号分为TP方案组(41例)和FP方案组(32例)。 TP方案组采用紫杉醇联合铂类药物诱导化疗;FP方案组采用5-氟尿嘧啶联合铂类药物诱导化疗。化疗均为2个疗程,配合后装92 Ir放疗,然后评价两组抗肿瘤效果,再进行手术治疗。结果两组治疗总有效率分别为75.6%和46.9%,TP方案组总有效率高于FP方案组( P<0.05)。两组化疗毒副反应强度差异无统计学意义( P均>0.05)。结论紫杉醇脂质体联合顺铂是一种非常有效的诱导化疗方案,有助于控制肿瘤,达到术前治疗的目的。
目的:評價紫杉醇脂質體聯閤順鉑方案作為誘導化療在宮頸癌治療中的抗腫瘤作用及毒性。方法選擇晚期宮頸癌患者73例,按照住院單、雙號分為TP方案組(41例)和FP方案組(32例)。 TP方案組採用紫杉醇聯閤鉑類藥物誘導化療;FP方案組採用5-氟尿嘧啶聯閤鉑類藥物誘導化療。化療均為2箇療程,配閤後裝92 Ir放療,然後評價兩組抗腫瘤效果,再進行手術治療。結果兩組治療總有效率分彆為75.6%和46.9%,TP方案組總有效率高于FP方案組( P<0.05)。兩組化療毒副反應彊度差異無統計學意義( P均>0.05)。結論紫杉醇脂質體聯閤順鉑是一種非常有效的誘導化療方案,有助于控製腫瘤,達到術前治療的目的。
목적:평개자삼순지질체연합순박방안작위유도화료재궁경암치료중적항종류작용급독성。방법선택만기궁경암환자73례,안조주원단、쌍호분위TP방안조(41례)화FP방안조(32례)。 TP방안조채용자삼순연합박류약물유도화료;FP방안조채용5-불뇨밀정연합박류약물유도화료。화료균위2개료정,배합후장92 Ir방료,연후평개량조항종류효과,재진행수술치료。결과량조치료총유효솔분별위75.6%화46.9%,TP방안조총유효솔고우FP방안조( P<0.05)。량조화료독부반응강도차이무통계학의의( P균>0.05)。결론자삼순지질체연합순박시일충비상유효적유도화료방안,유조우공제종류,체도술전치료적목적。
Objective To evaluate the efficacy and toxicity of paclitaxel liposome combined with cisplatin as induction chemotherapy in the treatment of cervical cancer .Methods Seventy-three patients who received chemo-therapy of paclitaxel liposome combined with cisplatin (TP program) and 5-fluorouracil(FP regimens) were retrospec-tively analyzed .There were 41 patients in TP group and 32 patients in FP group .All patients received induction chemo-therapy combined with the afterloading radiotherapy 15~20 Gy for two courses of treatment .Results The efficiency of TP group and FP group were 75.6%and 46.9%respectively , the efficient of TP group was higer than FP group ( P<0.05 ) ,there was no statistically significant difference in the toxic side effects between two groups ( P all >0.05 ) . Conclusion Chemotherapy of paclitaxel liposome combined with cisplatin is a very effective induction chemotherapy which can control the progression of tumor and treat the tumor before surgery .